The battle against COVID-19 vaccine hesitancy—an issue for nearly a quarter of Americans recently polled—can be won if messages promoting vaccination suggest most people will take it and political...

Soon after rapamycin, the first mTOR inhibitor, emerged in 1990s as a potential treatment against unwanted cell proliferation, many cancer experts had hoped emerging drugs targeting mTOR would become...